Metz Advisory LLP, a promoter group entity, sold 10,50,000 Metropolis Healthcare shares in an open market sale on August 11, 2026. Their stake decreased from 30.26% to 29.76%.
One of India's leading diagnostics companies, Metropolis Healthcare operates an extensive chain of diagnostic centres providing pathology and radiology services across multiple regions. The company maintains a widespread presence in India, South Asia, Africa, and the Middle East, offering comprehensive laboratory testing and imaging solutions to patients and healthcare providers. Its network focuses on delivering accurate diagnostics and quality healthcare services through modern facilities and trained professionals.
